Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.

Identifieur interne : 000094 ( Main/Exploration ); précédent : 000093; suivant : 000095

The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.

Auteurs : Subham Das [Inde] ; Anu Kunnath Ramachandran [Inde] ; Sumit Raosaheb Birangal [Inde] ; Saleem Akbar [Inde] ; Bahar Ahmed [Inde] ; Alex Joseph [Inde]

Source :

RBID : pubmed:33846702

Abstract

Recently, the pandemic outbreak of a novel coronavirus, officially termed as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), indicated by a pulmonary infection in humans, has become one of the most significant challenges for public health. In the current fight against coronavirus disease-2019, the medical and health authorities across the world focused on quick diagnosis and isolation of patients; meanwhile, researchers worldwide are exploring the possibility of developing vaccines and novel therapeutic options to combat this deadly disease. Recently, based on various small clinical observations, uncontrolled case studies and previously reported antiviral activity against SARS-CoV-1 chloroquine (CQ) and hydroxychloroquine (HCQ) have attracted exceptional consideration as possible therapeutic agents against SARS-CoV-2. However, there are reports on little to no effect of CQ or HCQ against SARS-CoV-2, and many reports have raised concerns about their cardiac toxicity. Here, in this review, we examine the chemistry, molecular mechanism, and pharmacology, including the current scenario and future prospects of CQ or HCQ in the treatment of SARS-CoV-2.

DOI: 10.1016/j.medidd.2021.100085
PubMed: 33846702
PubMed Central: PMC8026171


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.</title>
<author>
<name sortKey="Das, Subham" sort="Das, Subham" uniqKey="Das S" first="Subham" last="Das">Subham Das</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Manipal McGill Centre for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Manipal McGill Centre for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ramachandran, Anu Kunnath" sort="Ramachandran, Anu Kunnath" uniqKey="Ramachandran A" first="Anu Kunnath" last="Ramachandran">Anu Kunnath Ramachandran</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Birangal, Sumit Raosaheb" sort="Birangal, Sumit Raosaheb" uniqKey="Birangal S" first="Sumit Raosaheb" last="Birangal">Sumit Raosaheb Birangal</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Akbar, Saleem" sort="Akbar, Saleem" uniqKey="Akbar S" first="Saleem" last="Akbar">Saleem Akbar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062</wicri:regionArea>
<wicri:noRegion>New Delhi 110062</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ahmed, Bahar" sort="Ahmed, Bahar" uniqKey="Ahmed B" first="Bahar" last="Ahmed">Bahar Ahmed</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062</wicri:regionArea>
<wicri:noRegion>New Delhi 110062</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Joseph, Alex" sort="Joseph, Alex" uniqKey="Joseph A" first="Alex" last="Joseph">Alex Joseph</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33846702</idno>
<idno type="pmid">33846702</idno>
<idno type="doi">10.1016/j.medidd.2021.100085</idno>
<idno type="pmc">PMC8026171</idno>
<idno type="wicri:Area/Main/Corpus">000114</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000114</idno>
<idno type="wicri:Area/Main/Curation">000114</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000114</idno>
<idno type="wicri:Area/Main/Exploration">000114</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.</title>
<author>
<name sortKey="Das, Subham" sort="Das, Subham" uniqKey="Das S" first="Subham" last="Das">Subham Das</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Manipal McGill Centre for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Manipal McGill Centre for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ramachandran, Anu Kunnath" sort="Ramachandran, Anu Kunnath" uniqKey="Ramachandran A" first="Anu Kunnath" last="Ramachandran">Anu Kunnath Ramachandran</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Birangal, Sumit Raosaheb" sort="Birangal, Sumit Raosaheb" uniqKey="Birangal S" first="Sumit Raosaheb" last="Birangal">Sumit Raosaheb Birangal</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Akbar, Saleem" sort="Akbar, Saleem" uniqKey="Akbar S" first="Saleem" last="Akbar">Saleem Akbar</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062</wicri:regionArea>
<wicri:noRegion>New Delhi 110062</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ahmed, Bahar" sort="Ahmed, Bahar" uniqKey="Ahmed B" first="Bahar" last="Ahmed">Bahar Ahmed</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062</wicri:regionArea>
<wicri:noRegion>New Delhi 110062</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Joseph, Alex" sort="Joseph, Alex" uniqKey="Joseph A" first="Alex" last="Joseph">Alex Joseph</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104</wicri:regionArea>
<wicri:noRegion>Karnataka 576104</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Medicine in drug discovery</title>
<idno type="eISSN">2590-0986</idno>
<imprint>
<date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Recently, the pandemic outbreak of a novel coronavirus, officially termed as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), indicated by a pulmonary infection in humans, has become one of the most significant challenges for public health. In the current fight against coronavirus disease-2019, the medical and health authorities across the world focused on quick diagnosis and isolation of patients; meanwhile, researchers worldwide are exploring the possibility of developing vaccines and novel therapeutic options to combat this deadly disease. Recently, based on various small clinical observations, uncontrolled case studies and previously reported antiviral activity against SARS-CoV-1 chloroquine (CQ) and hydroxychloroquine (HCQ) have attracted exceptional consideration as possible therapeutic agents against SARS-CoV-2. However, there are reports on little to no effect of CQ or HCQ against SARS-CoV-2, and many reports have raised concerns about their cardiac toxicity. Here, in this review, we examine the chemistry, molecular mechanism, and pharmacology, including the current scenario and future prospects of CQ or HCQ in the treatment of SARS-CoV-2.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">33846702</PMID>
<DateRevised>
<Year>2021</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">2590-0986</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<PubDate>
<Year>2021</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Medicine in drug discovery</Title>
<ISOAbbreviation>Med Drug Discov</ISOAbbreviation>
</Journal>
<ArticleTitle>The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.</ArticleTitle>
<Pagination>
<MedlinePgn>100085</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medidd.2021.100085</ELocationID>
<Abstract>
<AbstractText>Recently, the pandemic outbreak of a novel coronavirus, officially termed as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), indicated by a pulmonary infection in humans, has become one of the most significant challenges for public health. In the current fight against coronavirus disease-2019, the medical and health authorities across the world focused on quick diagnosis and isolation of patients; meanwhile, researchers worldwide are exploring the possibility of developing vaccines and novel therapeutic options to combat this deadly disease. Recently, based on various small clinical observations, uncontrolled case studies and previously reported antiviral activity against SARS-CoV-1 chloroquine (CQ) and hydroxychloroquine (HCQ) have attracted exceptional consideration as possible therapeutic agents against SARS-CoV-2. However, there are reports on little to no effect of CQ or HCQ against SARS-CoV-2, and many reports have raised concerns about their cardiac toxicity. Here, in this review, we examine the chemistry, molecular mechanism, and pharmacology, including the current scenario and future prospects of CQ or HCQ in the treatment of SARS-CoV-2.</AbstractText>
<CopyrightInformation>© 2021 The Authors.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Das</LastName>
<ForeName>Subham</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Manipal McGill Centre for Infectious Diseases, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ramachandran</LastName>
<ForeName>Anu Kunnath</ForeName>
<Initials>AK</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Birangal</LastName>
<ForeName>Sumit Raosaheb</ForeName>
<Initials>SR</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Akbar</LastName>
<ForeName>Saleem</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ahmed</LastName>
<ForeName>Bahar</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Joseph</LastName>
<ForeName>Alex</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2021</Year>
<Month>03</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Med Drug Discov</MedlineTA>
<NlmUniqueID>101765689</NlmUniqueID>
<ISSNLinking>2590-0986</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Chloroquine</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">Cytokine storm</Keyword>
<Keyword MajorTopicYN="N">Hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
</KeywordList>
<CoiStatement>The authors declare no conflict of interest.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2021</Year>
<Month>01</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2021</Year>
<Month>02</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2021</Year>
<Month>02</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>4</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>29</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33846702</ArticleId>
<ArticleId IdType="doi">10.1016/j.medidd.2021.100085</ArticleId>
<ArticleId IdType="pii">S2590-0986(21)00006-3</ArticleId>
<ArticleId IdType="pmc">PMC8026171</ArticleId>
</ArticleIdList>
<pmc-dir>pmcsd</pmc-dir>
<ReferenceList>
<Reference>
<Citation>J Clin Virol. 2001 Feb;20(3):131-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11166661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med. 1983 Jul 18;75(1A):5-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6603166</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2008 Feb;77(2):150-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18055026</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2020 Mar 27;367(6485):1412-1413</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32217705</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2004 Aug;10(8):871-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15247913</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ned Tijdschr Geneeskd. 1988 Feb 20;132(8):332-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3283571</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neuropharmacol. 2021 Jan 13;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33441073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Crit Care Med. 2010 Oct;38(10 Suppl):S569-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21164399</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biomol Struct Dyn. 2020 Jul 6;:1-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32469265</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neuropharmacol. 2020 Aug 07;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32851951</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Discov Ther. 2020;14(1):58-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32147628</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Interferon Cytokine Res. 2015 Mar;35(3):143-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25321315</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Aug 15;396(10249):467-478</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32702298</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacokinet. 1996 Mar;30(3):194-210</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8882301</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pediatr Infect Dis J. 2020 Jul;39(7):e123-e124</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32427644</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacokinet. 1996 Oct;31(4):257-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8896943</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Dec 1;324(21):2165-2176</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33165621</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hum Exp Toxicol. 1992 Mar;11(2):117-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1349217</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antivir Chem Chemother. 2006;17(5):275-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17176632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Postgrad Med J. 2020 Sep;96(1139):550-555</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32295814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 2000 Dec;27(12):2927-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11128688</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacogenomics. 2007 Feb;8(2):187-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17286541</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virol J. 2006 May 29;3:39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16729896</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect. 2020 Apr;80(4):469-496</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32092392</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Pathol. 2004 Apr;121(4):507-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15080302</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Ophthalmol. 1991 Aug;23(8):292-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1952638</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 May;55(5):105938</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32171740</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Pharmacol. 1988 Sep;26(3):303-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3179169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Adv Res. 2020 Mar 16;24:91-98</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32257431</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Med. 2021 Dec;53(1):117-134</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33095083</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med. 1983 Jul 18;75(1A):11-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6408923</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Heart J. 1993 May;69(5):451-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8518071</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2021 Mar;19(3):155-170</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33116300</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Pharmacol. 1993;44(5):481-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8359187</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1991 Dec;65(12):7008-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1658391</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1994 Oct;68(10):6523-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8083990</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Omega. 2018 Dec 31;3(12):18132-18141</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30613818</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Jun;92(6):540-545</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32108352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Med Scand. 1982;211(5):411-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7113754</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lupus. 2009 Feb;18(2):104-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19151110</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2017 Mar 8;21(3):356-366</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28279346</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Future Med Chem. 2020 Nov;12(21):1961-1990</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33124462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Life Sci. 2020 Sep 1;256:117883</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32497632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2007 Oct;30(4):297-308</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17629679</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Pharmacol. 2000 Jun;49(6):549-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10848718</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dermatol Ther. 2007 Jul-Aug;20(4):160-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17970883</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 2008 Sep;62(3):437-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18565970</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Metab Dispos. 2003 Jun;31(6):748-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12756207</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Inform Med Unlocked. 2020;19:100345</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32395606</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Rheumatol. 2018 Dec;14(12):693-703</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30401979</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med. 1987 Mar;82(3):447-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3826099</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Pharmacol. 1994 Jul;38(1):15-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7946932</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Metab Syndr. 2020 May - Jun;14(3):241-246</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32247211</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9065-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18550812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2009 Aug;53(8):3416-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19506054</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 1998 Aug;25(8):1493-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9712089</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virol J. 2005 Aug 22;2:69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16115318</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biomol Struct Dyn. 2020 Jun 24;:1-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32579059</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>South Med J. 1992 Mar;85(3):274-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1546352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>OMICS. 2020 Oct;24(10):568-580</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32757981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 1948 May;27(3 Pt 2):98-107</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16695643</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2010 May;82(5):817-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20336760</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ophthalmic Res. 1995;27 Suppl 1:150-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8577454</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rheumatology (Oxford). 2006 Jun;45(6):703-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16418198</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2013 Aug;99(2):100-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23648708</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Pharmacol. 1989 Jun;27(6):771-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2757893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Oct 3;396(10256):e53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32971041</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ther Drug Monit. 1989;11(4):369-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2662478</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Apr;55(4):105932</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32145363</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24841269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Virol. 1984;81(3-4):377-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6148053</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vopr Virusol. 2008 Jul-Aug;53(4):9-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18756809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Biochem Funct. 2016 Jun;34(4):191-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27001679</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2005 Mar;5(3):184-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15766653</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Sep;56(3):106119</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32738306</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Mol Sci. 2020 May 30;21(11):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32486229</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Oct 8;323(1):264-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15351731</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Res Ther. 2009;11(4):R109</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19604357</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Life Sci. 2020 Oct 1;258:118202</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32758625</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Immunol. 2004 Mar;135(3):467-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15008980</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Toxicol Environ Health. 1977 May;2(5):977-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">405503</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Pharmacol Rep. 2020 Aug 24;:1-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32864299</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Rheumatol. 1994 Mar;33(3):235-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8156285</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2004 Apr 1;189(7):1164-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15031783</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS Res Ther. 2017 Sep 12;14(1):46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28893304</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1998 Jul;72(7):6207-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9621091</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2011 May 10;413(2):265-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21435673</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lupus. 1996 Jun;5 Suppl 1:S11-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8803904</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2006 Feb;6(2):67-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16439323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2004 Sep;50(9):3056-7; author reply 3057-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15457485</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunology. 2002 Jan;105(1):83-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11849318</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Pharmacol Toxicol (Copenh). 1970;28(1):64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4996677</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Chem. 2006 May 4;49(9):2845-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16640347</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Oct 3;396(10256):e54-e55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32971043</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Nov;92(11):2693-2701</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32497323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Rheumatol. 2017 Mar;44(3):398</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28250164</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lupus. 1993 Feb;2 Suppl 1:S17-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8485566</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<country name="Inde">
<noRegion>
<name sortKey="Das, Subham" sort="Das, Subham" uniqKey="Das S" first="Subham" last="Das">Subham Das</name>
</noRegion>
<name sortKey="Ahmed, Bahar" sort="Ahmed, Bahar" uniqKey="Ahmed B" first="Bahar" last="Ahmed">Bahar Ahmed</name>
<name sortKey="Akbar, Saleem" sort="Akbar, Saleem" uniqKey="Akbar S" first="Saleem" last="Akbar">Saleem Akbar</name>
<name sortKey="Birangal, Sumit Raosaheb" sort="Birangal, Sumit Raosaheb" uniqKey="Birangal S" first="Sumit Raosaheb" last="Birangal">Sumit Raosaheb Birangal</name>
<name sortKey="Das, Subham" sort="Das, Subham" uniqKey="Das S" first="Subham" last="Das">Subham Das</name>
<name sortKey="Joseph, Alex" sort="Joseph, Alex" uniqKey="Joseph A" first="Alex" last="Joseph">Alex Joseph</name>
<name sortKey="Ramachandran, Anu Kunnath" sort="Ramachandran, Anu Kunnath" uniqKey="Ramachandran A" first="Anu Kunnath" last="Ramachandran">Anu Kunnath Ramachandran</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000094 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000094 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33846702
   |texte=   The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33846702" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021